Literature DB >> 11137615

Immunomodulators in infectious diseases: panoply of possibilites.

K N Masihi1.   

Abstract

Infections which caused ravages in the past centuries are again resurgent and newly emerging pathogens capable of human diseases continue to surface. Multidrug antibiotic resistance has turned into a major medical problem. Judicious concepts for combating infections in the 21st century have acquired a new poignancy. Immunomodulators of natural, synthetic, and recombinant origin can stimulate host defense mechanisms for the prophylaxis and treatment of diverse viral, bacterial, parasitic and fungal diseases. Some immunomodulator preparations are already licensed for use in patients and numerous others are being extensively investigated in preclinical and clinical studies. Immunomodulators offer a novel adjunct to established antimicrobial therapies.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11137615     DOI: 10.1016/s0192-0561(00)00074-6

Source DB:  PubMed          Journal:  Int J Immunopharmacol        ISSN: 0192-0561


  11 in total

Review 1.  Concepts of immunostimulation to increase antiparasitic drug action.

Authors:  K Noel Masihi
Journal:  Parasitol Res       Date:  2003-01-08       Impact factor: 2.289

2.  Development of Anti-Yersinia pestis Human Antibodies with Features Required for Diagnostic and Therapeutic Applications.

Authors:  Antonietta M Lillo; Nileena Velappan; Julia M Kelliher; Austin J Watts; Samuel P Merriman; Grace Vuyisich; Laura M Lilley; Kent E Coombs; Tara Mastren; Munehiro Teshima; Benjamin W Stein; Gregory L Wagner; Srinivas Iyer; Andrew R M Bradbury; Jennifer Foster Harris; Armand E Dichosa; Stosh A Kozimor
Journal:  Immunotargets Ther       Date:  2020-11-27

3.  Effect of lipopolysaccharide (LPS) from Ochrobactrum intermedium on sheep experimentally infected with Fasciola hepatica.

Authors:  J M Martínez-Pérez; D Robles-Pérez; F Valcárcel-Sancho; A M González-Guirado; I Casanova-García de Castro; J M Nieto-Martínez; F A Rojo-Vázquez; M Martínez-Valladares
Journal:  Parasitol Res       Date:  2013-06-06       Impact factor: 2.289

4.  Enhanced immunological memory responses to Listeria monocytogenes in rodents, as measured by delayed-type hypersensitivity (DTH), adoptive transfer of DTH, and protective immunity, following Lactobacillus casei Shirota ingestion.

Authors:  R de Waard; E Claassen; G C A M Bokken; B Buiting; J Garssen; J G Vos
Journal:  Clin Diagn Lab Immunol       Date:  2003-01

5.  Immune modulator adamantylamide dipeptide stimulates efficient major histocompatibility complex class I-restricted responses in mice.

Authors:  Pablo D Becker; Miriam Nörder; Carlos A Guzmán; Saul Grinstein
Journal:  Clin Vaccine Immunol       Date:  2007-03-07

Review 6.  Antibiotic alternatives: the substitution of antibiotics in animal husbandry?

Authors:  Guyue Cheng; Haihong Hao; Shuyu Xie; Xu Wang; Menghong Dai; Lingli Huang; Zonghui Yuan
Journal:  Front Microbiol       Date:  2014-05-13       Impact factor: 5.640

7.  Topical Simvastatin as Host-Directed Therapy against Severity of Cutaneous Leishmaniasis in Mice.

Authors:  Suraj P Parihar; Mary-Anne Hartley; Ramona Hurdayal; Reto Guler; Frank Brombacher
Journal:  Sci Rep       Date:  2016-09-16       Impact factor: 4.379

8.  Mesenchymal stem cell therapy promotes the improvement and recovery of renal function in a preclinical model.

Authors:  Antônio Urt-Filho; Rodrigo Juliano Oliveira; Larissa Correa Hermeto; João Renato Pesarini; Natan de David; Wilson de Barros Cantero; Gustavo Falcão; Guido Marks; Andréia Conceição Milan Brochado Antoniolli-Silva
Journal:  Genet Mol Biol       Date:  2016-06-03       Impact factor: 1.771

Review 9.  Antimicrobial Resistance: Its Surveillance, Impact, and Alternative Management Strategies in Dairy Animals.

Authors:  Chetan Sharma; Namita Rokana; Mudit Chandra; Brij Pal Singh; Rohini Devidas Gulhane; Jatinder Paul Singh Gill; Pallab Ray; Anil Kumar Puniya; Harsh Panwar
Journal:  Front Vet Sci       Date:  2018-01-08

10.  In vivo evaluation of the antimutagenic and antigenotoxic effects of β-glucan extracted from Saccharomyces cerevisiae in acute treatment with multiple doses.

Authors:  Rodrigo Juliano Oliveira; Maria José Sparça Salles; Ariane Fernanda da Silva; Tatiane Yumi Nakamura Kanno; Ana Carolina Dos Santos Lourenço; Véssia da Silva Leite; Hevenilton José Matiazi; João Renato Pesarini; Lúcia Regina Ribeiro; Mário Sérgio Mantovani
Journal:  Genet Mol Biol       Date:  2013-07-19       Impact factor: 1.771

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.